SEATTLE & INNSBRUCK, Austria, May 20, 2024 Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005 (ebselen) trial is to reduce the loss of residual hearing during and after CI. Ebselen is a novel anti-inflammatory compound that mimics and induces the activity of Glutathione Peroxidase, an enzyme that is c
Study reveals bacterial protein capable of keeping human cells healthy phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.
The quest for youth has existed for centuries, despite the inevitable effects of time on the body. Research shows that skin aging in particular strongly depends on the genetic capital and lifestyle of each individual, in addition to external factors such as pollution, UV rays. Is it possible to slow the aging process down? This is certainly one of the consumer concerns of this century: to age; yes, but to age well and stay healthy. Consumers are increasingly attuned to the values of the.
Jacob Brown of the Oklahoma Medical Research Foundation will discuss targeting oxygenated lipids as an effective strategy to ameliorate sarcopenia and cancer cachexia at 12:55 p.m. Wednesday in BELL 2267.
/PRNewswire/ Sound Pharmaceuticals, Inc. (SPI) is pleased to announce that is has received a $1.1M supplement to its $3.1M National Center for Advancing.